Accenture vs Johnson & Johnson: Founders, CEOs and History
Accenture was founded in 1989 by Arthur Andersen Consulting Partners, George Shaheen and is led by Julie Sweet. Johnson & Johnson was founded in 1886 by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson and is led by Joaquin Duato.
Company facts
Accenture
- Founded
- 1989
- Headquarters
- Dublin, Ireland
- Current CEO
- Julie Sweet
- Employees
- 799,000
Johnson & Johnson
- Founded
- 1886
- Headquarters
- New Brunswick, New Jersey
- Current CEO
- Joaquin Duato
- Employees
- 140,800
Founders
Accenture
Arthur Andersen Consulting Partners
Accenture has no single founder. It began in the early 1950s as the business and technology consulting practice of Arthur Andersen, the accounting firm founded in 1913.
George Shaheen
George Shaheen led Andersen Consulting from 1989 until September 1999. By the time he left, the consulting unit had about 65,000 staff. In 1997 it began the ICC arbitration to separate from Arthur Andersen.
Johnson & Johnson
Robert Wood Johnson
Robert Wood Johnson (1845-1910) co-founded Johnson & Johnson in 1886 and served as its first president.
James Wood Johnson
James Wood Johnson (1856-1932) co-founded J&J with his brothers in 1886. An engineer by trade, he designed the early manufacturing machinery that allowed the company to mass-produce sterile surgical dressings.
Edward Mead Johnson
Edward Mead Johnson (1852-1934) co-founded J&J in 1886, bringing crucial sales and marketing expertise to the early business.
CEOs and their tenures
Accenture
- George Shaheen1989–1999
Managing Partner and CEO, Andersen Consulting
Led Andersen Consulting from its 1989 formation as a separate unit of Andersen Worldwide until September 1999, a period in which the consulting unit grew to about 65,000 employees and began the 1997 ICC arbitration to leave Arthur Andersen.
Source - Joe Forehand1999–2004
CEO
Succeeded Shaheen in November 1999 as global managing partner and CEO. Led the firm through the August 2000 arbitration ruling, the January 1, 2001 rename to Accenture and the July 19, 2001 NYSE IPO at $14.50 per share.
Source - William D. Green2004–2011
CEO
CEO from Sept 1, 2004 to January 2011, after serving as chief operating officer for client services. Revenue was $23.09B in FY2010, his last full fiscal year as CEO.
Source - Pierre Nanterme2011–2019
CEO
CEO from January 2011 and also chairman from February 2013. Revenue grew from $27.35B in FY2011 to $41.60B in FY2018 as originally reported.
Source - David Rowland2019–2019
Interim CEO
Chief financial officer who served as interim CEO from Jan 10, 2019 after Nanterme stepped down, until Julie Sweet took over on Sept 1, 2019.
Source - Julie Sweet2019–present
Chair and CEO
CEO since Sept 1, 2019 and chair since Sept 1, 2021; previously CEO of Accenture North America and, before that, general counsel. Revenue rose from $44.33B in FY2020 to $69.67B in FY2025, and headcount reached about 799,000 by May 31, 2026.
Source
Johnson & Johnson
- Ralph Larsen1989–2002
Former Chairman and Chief Executive Officer
Larsen's acquisitions, including Neutrogena, Cordis, DePuy, and Centocor, broadened J&J into medical devices and biologics, laying groundwork for today's MedTech segment and immunology franchise.
Source - William Weldon2002–2012
Former Chairman and Chief Executive Officer
Weldon's later years were overshadowed by a wave of consumer product recalls, including Tylenol and Motrin, tied to manufacturing-quality problems.
Source - Alex Gorsky2012–2022
Former Chairman and Chief Executive Officer
Gorsky's tenure set up the 2023 Kenvue separation completed under his successor and saw J&J's single-dose COVID-19 vaccine authorized in 2021. He also oversaw the $30 billion Actelion acquisition in 2017 and the early years of talc litigation.
Source - Joaquin Duato2022–present
Chairman and Chief Executive Officer
Under Duato, J&J's sales reached $94.193 billion in FY2025 with $26.804 billion in net earnings, and the company guides to its first $100 billion year in 2026. He also launched the DePuy Synthes separation and the 2026 talc settlement proposal.
Source
Timeline: Accenture and Johnson & Johnson side by side
1886Johnson & Johnson
Johnson & Johnson Founded
Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson found the company in New Brunswick, New Jersey, with 14 employees, to mass-produce sterile surgical dressings after Robert was inspired by antiseptic pioneer Joseph Lister's 1885 warnings about i…
1920Johnson & Johnson
Band-Aid Brand Adhesive Bandages Introduced
J&J introduces the first mass-produced adhesive bandage, sold under the Band-Aid brand starting in 1921; it becomes one of the most recognized consumer-health brands in the world before J&J later spins its consumer division out as Kenvue in 2023.
1943Johnson & Johnson
Robert Wood Johnson II Writes 'Our Credo'
Chairman Robert Wood Johnson II authors 'Our Credo,' a one-page statement ranking the company's responsibilities to customers, employees, communities, and shareholders in that order; it remains J&J's official governing philosophy and was later cited as the bas…
1944Johnson & Johnson
J&J Goes Public
Johnson & Johnson lists publicly, becoming an independent, market-traded company as it expands into a diversified healthcare business under Chairman Robert Wood Johnson II.
1953Accenture
Arthur Andersen GE feasibility study
Arthur Andersen's administrative services group, led by Joseph Glickauf, carries out a study for General Electric on computerizing payroll at Appliance Park in Louisville, Kentucky.
1982Johnson & Johnson
Tylenol Cyanide Poisonings and Nationwide Recall
After seven people in the Chicago area die from cyanide-laced Extra-Strength Tylenol capsules, J&J issues a nationwide recall of 31 million bottles within a week -- far beyond what investigators said was necessary -- citing Our Credo's customer-safety priority…
1989Accenture
Andersen Consulting formed
Arthur Andersen and Andersen Consulting become separate units of Andersen Worldwide Societe Cooperative, with George Shaheen as managing partner and CEO of the consulting unit. The more profitable unit pays the other up to 15% of profits.
1997Accenture
Arbitration with Arthur Andersen begins
Andersen Consulting files an arbitration claim with the International Chamber of Commerce, arguing that Arthur Andersen broke their agreement by building its own competing consulting practice.
2000Accenture
Arbitration ruling and Avanade
In April 2000 Andersen Consulting and Microsoft form Avanade, a joint venture now majority owned by Accenture.
2001Accenture
Rename to Accenture and NYSE IPO
Andersen Consulting becomes Accenture on Jan 1, 2001, a name based on "Accent on the future" suggested by an employee in Oslo. The Bermuda-incorporated company prices its IPO at $14.50 per share and starts trading on the NYSE on July 19, 2001.
2004Accenture
William D. Green becomes CEO
William D. Green succeeds Joe Forehand as CEO on Sept 1, 2004; Forehand remains chairman.
2009Accenture
Reincorporation in Ireland
On May 26, 2009 the board approves moving the company's place of incorporation from Bermuda to Ireland, which remains its legal domicile.
2011Accenture
Pierre Nanterme becomes CEO
Pierre Nanterme becomes CEO in January 2011. The same year Accenture completes its purchase of insurance software company Duck Creek Technologies.
2012Johnson & Johnson
Alex Gorsky Becomes CEO
Gorsky succeeds William Weldon as CEO amid a period of manufacturing-quality recalls, and spends the next decade restoring J&J's operational reputation while expanding the pharmaceutical and MedTech businesses and developing a single-dose COVID-19 vaccine duri…
2013Accenture
Fjord acquisition
Accenture agrees in May 2013 to acquire Fjord, a service design consultancy, adding design capacity to Accenture Interactive.
2016Accenture
Duck Creek stake sold to Apax
Funds advised by Apax Partners buy a 60% stake in Duck Creek Technologies from Accenture, which keeps 40%.
2019Accenture
CEO transition and Droga5
Nanterme steps down for health reasons on Jan 11, 2019 and CFO David Rowland becomes interim CEO. Accenture Interactive completes the purchase of creative agency Droga5, and Julie Sweet becomes CEO on Sept 1, 2019.
2022Accenture
Accenture Song
On April 26, 2022 Accenture Interactive begins going to market as Accenture Song. FY2022 revenue rises 22% to $61.59B.
2022Johnson & Johnson
Joaquin Duato Becomes CEO
Duato becomes CEO in January 2022, later adding the chairman title, and begins preparing the separation of J&J's consumer-health business from its medicine and device operations.
2023Accenture
$3B Data & AI investment
In June 2023 Accenture announces a $3B investment over three years in its Data & AI practice and a plan to double AI talent to 80,000 people.
2023Johnson & Johnson
Kenvue Separation
J&J completes the spinoff of its consumer-health business (Band-Aid, Tylenol, Listerine, Neutrogena) as the standalone public company Kenvue, narrowing J&J around its higher-margin Innovative Medicine and MedTech segments.
2024Accenture
Udacity acquisition
Accenture completes its purchase of online education company Udacity on May 20, 2024 to support its Accenture LearnVantage training business.
2025Accenture
FY2025 results and restructuring
FY2025 revenue reaches $69.67B with $80.62B in new bookings. In September 2025 Accenture outlines a six-month, $865M business optimization program, mainly severance, and moves to a single Reinvention Services unit.
2025Johnson & Johnson
FY2025 Sales of $94.193B
Johnson & Johnson reports $94.193 billion in sales and $26.804 billion in net earnings, split roughly 64% Innovative Medicine and 36% MedTech, both segments growing about 6% year over year.
2025Johnson & Johnson
Orthopaedics Separation Announced
In October 2025 J&J announced plans to separate its orthopaedics business as a standalone company operating as DePuy Synthes, targeting completion in 2027.
2026Accenture
Faculty and Ookla deals
Accenture completes the acquisition of UK AI company Faculty on March 16, 2026 and agrees in March 2026 to buy Ziff Davis's connectivity division (Ookla, Speedtest, Downdetector) for $1.2B in cash. Q3 FY2026 revenue is $18.72B.
2026Johnson & Johnson
Proposed Talc Resolution and Raised Guidance
J&J raised 2026 sales guidance to about $101.1 billion after Q2 sales of $25.31 billion, and on July 27, 2026 proposed an estimated $5.5 billion resolution of remaining ovarian talc claims.
Acquisitions
Accenture
- Faculty2026Undisclosed
- Ookla (Ziff Davis Connectivity division)2026$1.2B
- Udacity2024Undisclosed
- umlaut2021Undisclosed
- Droga52019Undisclosed
- Fjord2013Undisclosed
Johnson & Johnson
- Intra-Cellular Therapies2025$14.6B
- Shockwave Medical2024$13.1B
- Kenvue separation2023Undisclosed
- Abiomed2022$16.6B
- Actelion2017$30B
Questions about Accenture vs Johnson & Johnson
Who is the CEO of Accenture PLC and Johnson & Johnson?
Accenture PLC is led by Julie Sweet and Johnson & Johnson is led by Joaquin Duato. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Accenture PLC founded vs Johnson & Johnson?
Johnson & Johnson was founded in 1886 — 103 years before Accenture PLC, which was founded in 1989. Johnson & Johnson's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Accenture PLC.
How many employees does Accenture PLC have compared to Johnson & Johnson?
Accenture PLC employs approximately 799,000 people, while Johnson & Johnson employs approximately 140,800. Accenture PLC has the larger workforce at 799,000 employees, compared to Johnson & Johnson's 140,800. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Accenture PLC and Johnson & Johnson headquartered?
Accenture PLC is headquartered in Ireland and Johnson & Johnson is headquartered in United States. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Accenture PLC and Johnson & Johnson?
Accenture PLC was founded by Arthur Andersen Consulting Partners, George Shaheen. Johnson & Johnson was founded by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson.
Which company has a longer operating history — Accenture PLC or Johnson & Johnson?
Johnson & Johnson has been operating for approximately 140 years, making it the more established of the two companies. Accenture PLC has been in operation for around 37 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Accenture vs Johnson & Johnson overview